LONG-TERM TREATMENT OF SCHIZOPHRENIA

被引:0
|
作者
HUBER, G
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:604 / 611
页数:8
相关论文
共 50 条
  • [31] Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
    Murasaki, Mitsukuni
    Inoue, Yoshifumi
    Nakamura, Hiroshi
    Kinoshita, Toshihiko
    ANNALS OF GENERAL PSYCHIATRY, 2021, 20 (01)
  • [32] Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
    Mitsukuni Murasaki
    Yoshifumi Inoue
    Hiroshi Nakamura
    Toshihiko Kinoshita
    Annals of General Psychiatry, 20
  • [33] CONTINUITY IN BIOLOGICAL TREATMENT - LONG-TERM NEUROLEPTIC TREATMENT OF SCHIZOPHRENIA
    OBRIEN, CP
    TIGNOL, J
    INTERNATIONAL JOURNAL OF MENTAL HEALTH, 1991, 20 (03) : 23 - 30
  • [34] Schizophrenia - Long-term progression and long-term history
    Dirksen-Fischer, M
    GESUNDHEITSWESEN, 2004, 66 (07) : 456 - 456
  • [35] Efficacy of aripiprazole (amdoal) in the long-term treatment of schizophrenia
    Tsukarzi, E. E.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (03) : 94 - 97
  • [36] TOLERABILITY OF REMOXIPRIDE IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA - AN OVERVIEW
    HOLM, AC
    EDSMAN, I
    LUNDBERG, T
    ODLIND, B
    DRUG SAFETY, 1993, 8 (06) : 445 - 456
  • [37] PREDICTORS OF FAVORABLE LONG-TERM OUTCOME IN THE TREATMENT OF SCHIZOPHRENIA
    Carter, Cuyun G.
    Milton, D.
    Faries, D.
    Ascher-Svanum, H.
    VALUE IN HEALTH, 2010, 13 (03) : A106 - A106
  • [38] The long-term treatment of schizophrenia with antipsychotics: a perennial debate
    Fleischhacker, W. Wolfgang
    WORLD PSYCHIATRY, 2018, 17 (02): : 169 - 170
  • [39] Long-term efficacy and safety of lurasidone in the treatment of schizophrenia
    Samalin, L.
    Honciuc, M.
    Llorca, P. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 (06): : 541 - 549
  • [40] Thinking long-term from the outset in the treatment of schizophrenia
    Jones, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S611 - S611